Clinical Trial

Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated April 25, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-03; most recent amendment 2025-04-24.
Status change: Not Yet Recruiting → Recruiting 2023-12-17
Trial Details
NCT Number NCT05756179
Lead Sponsor Alexandria University
Conditions Rheumatoid Arthritis
Enrollment 80 participants
Start Date 2023-07-18
Primary Completion 2025-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-25